Ifuji Sangyo (2924) Q3 2023 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2023 earnings summary
16 Oct, 2026Executive summary
Q3 FY2023 cumulative revenue, operating profit and ordinary profit reached record highs for the period, supported by higher liquid-egg sales volumes and selling prices.
Revenue rose 6.9% YoY to ¥14,619m; operating profit increased 3.3% to ¥1,125m, while attributable net income declined 5.7% to ¥797m.
Financial highlights
Revenue was ¥14,619m (+6.9% YoY), operating profit ¥1,125m (+3.3%), and ordinary profit ¥1,156m (+3.9%).
Attributable net income was ¥797m (-5.7% YoY); prior-year net income included a ¥72m additional deferred tax asset recognition, with no comparable addition this period.
Comprehensive income was ¥800m, down from ¥836m in the prior-year period.
Outlook and guidance
FY2023 guidance remains unchanged: revenue ¥18,059m (+3.6%), operating profit ¥1,333m (+0.6%), ordinary profit ¥1,358m (+0.1%) and net income ¥919m (-7.7%).
Forecast EPS is ¥112.13; results were described as generally progressing as planned, despite uncertainty in egg supply and market prices.
Latest events from Ifuji Sangyo
- Record Q1 sales volume and profit, despite sharply lower egg prices.2924
Q1 2025 - Profit rose on liquid egg volume growth and cost controls despite lower revenue.2924
Q1 2023 - Lower egg prices trimmed sales, but H1 operating and ordinary income hit records.2924
Q2 2023 - Record FY25 earnings support capacity expansion as FY26 profit is forecast to decline.2924
Q4 2025 - Record H1 operating profit amid lower egg prices; FY guidance and dividend raised.2924
Q2 2025 - Record FY2023 results meet a severe egg-supply crunch and slower FY2024 profit growth.2924
Q4 2023 - Record FY2024 results; FY2025 revenue is forecast lower, with operating profit higher.2924
Q4 2024 - Record H1 profits amid egg-price inflation, supply constraints, and inventory-driven cash outflow.2924
Q2 2024 - Record liquid egg volumes and lower input costs lifted 9M profit to new highs.2924
Q3 2025